Trade Regeneron Pharmaceuticals, Inc. - REGN CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 6.46
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022179 %(-$4.44)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02218%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000043 %(-$0.01)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.01
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022179 %
  (-$4.44)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000043 %
  (-$0.01)

Key Stats

• Prev. Close: 735.17
• Open: 729.77
• 1-Year Change: 21.64%
• Day's Range: 729.77 - 733.77

Trade Regeneron Pharmaceuticals, Inc. - REGN

What is Regeneron Pharmaceuticals, Inc. (REGN)?

Regeneron Pharmaceuticals, Inc. is a biotechnology company engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company focuses on areas such as ophthalmology, oncology, immunology, and infectious diseases. It utilizes proprietary technologies to develop therapeutic antibodies and other biologics. Regeneron operates research and manufacturing facilities and collaborates with academic institutions and other companies to advance drug development. Its portfolio includes several approved products and a pipeline of investigational therapies. The company is headquartered in Tarrytown, New York.

Regeneron Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by trading flows as Regeneron Pharmaceuticals, Inc. trades at $740.23. The intraday price has moved from $728.81 to $739.77, with a daily change of 0%.

FAQ: Regeneron Pharmaceuticals, Inc. (REGN)

What is the current price of REGN stock?

Regeneron Pharmaceuticals, Inc.'s stock price is $740.23.

Does REGN pay dividends?

Regeneron Pharmaceuticals, Inc. does not pay dividends.

Does REGN have a formal corporate presence or regional headquarters in the UAE?

Regeneron Pharmaceuticals, Inc. operates in the UAE via partnerships without a direct office.

What is REGN best known for?

The company is most famous for its development of innovative biopharmaceutical products.

What assets are typically shown together with REGN?

Commonly shown alongside REGN: Huntsman, Reece Limited, SPDR S&P U.S. Financials Select Sector UCITS ETF